Home - Xtalks

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Upcoming Webinars

View All

February 10, 2026

Centralize to Modernize: A Stepwise Path to Agile Clinical Operations

February 11, 2026

How Early Protocol Design Shapes Supply Strategy and RTSM Readiness

February 18, 2026

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks

February 19, 2026

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

February 19, 2026

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

February 20, 2026

Site Selection Solutions Using Patient Insights for Rare Disease Trials

February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)

February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)

February 10, 2026

Centralize to Modernize: A Stepwise Path to Agile Clinical Operations

February 11, 2026

How Early Protocol Design Shapes Supply Strategy and RTSM Readiness

February 18, 2026

Transforming Pediatric Rare Disease Trials Through Modeling and Simulation, and Site Networks

February 19, 2026

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

February 19, 2026

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

February 20, 2026

Site Selection Solutions Using Patient Insights for Rare Disease Trials

February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)

February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)

On-Demand Webinars

View All

February 05, 2026

Emerging LNP Technology and mRNA Strategies for In Vivo CAR-T Development

February 04, 2026

Blood and Beyond: Unlocking Biological Insights from Novel Sample Types

February 03, 2026

Continuous Biologics Manufacturing for Modular and Sustainable Operations

February 03, 2026

Decoding Alzheimer’s disease: trial designs, biomarker breakthroughs, and redefining patient-first strategies

February 05, 2026

Emerging LNP Technology and mRNA Strategies for In Vivo CAR-T Development

February 04, 2026

Blood and Beyond: Unlocking Biological Insights from Novel Sample Types

February 03, 2026

Continuous Biologics Manufacturing for Modular and Sustainable Operations

February 03, 2026

Decoding Alzheimer’s disease: trial designs, biomarker breakthroughs, and redefining patient-first strategies

Featured Editorial

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All

FDA Seeks Additional Information on Subcutaneous Anifrolumab BLA

FDA complete response letter anifrolumab, subcutaneous anifrolumab, anifrolumab astrazeneca

News February 5, 2026

What Most Often Delays Clinical Trial Timelines?

Life Sciences Quizzes & Polls February 5, 2026

World Cancer Day 2026: A Focus on Prevention and Raising Treatment Bars

Blogs February 4, 2026

FDA Seeks Additional Information on Subcutaneous Anifrolumab BLA

News February 5, 2026

What Most Often Delays Clinical Trial Timelines?

Life Sciences Quizzes & Polls February 5, 2026

World Cancer Day 2026: A Focus on Prevention and Raising Treatment Bars

Blogs February 4, 2026

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All